Managed Account Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Other funds holding RARE
CWAM
BFA
Managed Account Advisors's RARE Position: Q2 2015 in Review
Managed Account Advisors reduced its Ultragenyx Pharmaceutical (RARE) stake by 20% in Q2 2015, selling an estimated $157K and leaving 7,944 shares worth $814K. The position accounts for ﹤0.01% of the portfolio, ranked #2171.
Managed Account Advisors first reported a position in RARE in Q1 2014 and has held it in 5 quarters since. 151 funds tracked by Wall St. Rank hold RARE as of Q2 2015.
- Managed Account Advisors held 7,944 shares of Ultragenyx Pharmaceutical worth $814K as of Q2 2015.
- Managed Account Advisors sold 2,017 Ultragenyx Pharmaceutical shares in Q2 2015, an estimated $157K.
- Ultragenyx Pharmaceutical made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2171 holding.
- Managed Account Advisors first reported a position in Ultragenyx Pharmaceutical in Q1 2014 and has held it in 5 quarters since.
- 151 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2015.
Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.